Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.89M | 23.43M | 17.11M | 15.49M | 12.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.40M | 53.56M | 46.21M | 42.45M | 36.04M |
| Operating Income | -34.40M | -53.56M | -46.21M | -42.45M | -36.04M |
| Income Before Tax | -35.36M | -13.73M | -7.92M | -5.94M | -18.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.36 | -13.73 | -7.92 | -5.94 | -18.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.36M | -13.73M | -7.92M | -5.94M | -18.46M |
| EBIT | -34.40M | -53.56M | -46.21M | -42.45M | -36.04M |
| EBITDA | -34.24M | -53.40M | -46.04M | -42.29M | -35.87M |
| EPS Basic | -0.23 | -0.09 | -0.14 | -0.14 | -0.29 |
| Normalized Basic EPS | -0.16 | -0.25 | -0.25 | -0.25 | -0.22 |
| EPS Diluted | -0.23 | -0.42 | -0.48 | -0.48 | -0.62 |
| Normalized Diluted EPS | -0.16 | -0.25 | -0.25 | -0.24 | -0.22 |
| Average Basic Shares Outstanding | 592.44M | 568.36M | 486.43M | 436.25M | 402.09M |
| Average Diluted Shares Outstanding | 592.44M | 573.42M | 491.48M | 441.31M | 407.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |